Potassium phosphate and Thrombocytopenia - a phase IV clinical study of FDA data
Summary:
Thrombocytopenia is reported as a side effect among people who take Potassium phosphate (potassium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ondansetron, and have Nausea.
The phase IV clinical study analyzes which people have Thrombocytopenia when taking Potassium phosphate. It is created by eHealthMe based on reports of 571 people who have side effects when taking Potassium phosphate from the FDA, and is updated regularly.
What is Potassium phosphate?
Potassium phosphate has active ingredients of potassium. eHealthMe is studying from 578 Potassium phosphate users. Check the latest studies of Potassium phosphate.
What is Thrombocytopenia?
Thrombocytopenia (decrease of platelets in blood) is found to be associated with 2,789 drugs and 4,873 conditions by eHealthMe. Check the latest studies of Thrombocytopenia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
571 people reported to have side effects when taking Potassium phosphate.
Among them, 33 people (5.78%) have Thrombocytopenia.

Among these 33 people:
How long have people been on Potassium phosphate when they have Thrombocytopenia? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Thrombocytopenia when taking Potassium phosphate? *
- female: 51.52 %
- male: 48.48 %
What is the age of people who have Thrombocytopenia when taking Potassium phosphate? *
- 0-1: 6.06 %
- 2-9: 0.0 %
- 10-19: 6.06 %
- 20-29: 3.03 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 9.09 %
- 60+: 75.76 %
What are other drugs people take besides Potassium phosphate? *
- Ondansetron: 15 people, 45.45%
- Heparin: 13 people, 39.39%
- Pantoprazole: 10 people, 30.30%
- Levaquin: 9 people, 27.27%
- Midazolam: 9 people, 27.27%
- Vfend: 9 people, 27.27%
- Magnesium: 8 people, 24.24%
- Morphine: 8 people, 24.24%
- Valtrex: 8 people, 24.24%
- Zyloprim: 7 people, 21.21%
What are other side effects people have besides Thrombocytopenia? *
- Fever: 18 people, 54.55%
- Anaemia (lack of blood): 14 people, 42.42%
- Hypotension (abnormally low blood pressure): 14 people, 42.42%
- Arrhythmias (irregular heartbeat): 13 people, 39.39%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 13 people, 39.39%
- Constipation: 12 people, 36.36%
- Fatigue (feeling of tiredness): 12 people, 36.36%
- Abdominal Pain: 11 people, 33.33%
- Sepsis (a severe blood infection that can lead to organ failure and death): 11 people, 33.33%
- Febrile Neutropenia (fever with reduced white blood cells): 11 people, 33.33%
What are the existing conditions these people have? *
- Pain: 15 people, 45.45%
- Nausea (feeling of having an urge to vomit): 15 people, 45.45%
- Indigestion: 14 people, 42.42%
- Constipation: 13 people, 39.39%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 11 people, 33.33%
- High Blood Pressure: 11 people, 33.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 21.21%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 18.18%
- Hypokalemia (low potassium): 6 people, 18.18%
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 6 people, 18.18%
* Approximation only. Some reports may have incomplete information.
Do you take Potassium phosphate and have Thrombocytopenia?
- Check whether Thrombocytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Potassium phosphate:
- Potassium phosphate (578 reports)
Thrombocytopenia treatments and more:
- Thrombocytopenia (285,083 reports)
How severe was Thrombocytopenia and when was it recovered:
Expand to all the drugs that have ingredients of potassium:
- Thrombocytopenia and drugs with ingredients of potassium (1,116 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Potassium phosphate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Thrombocytopenia:
- Thrombocytopenia (2,789 drugs)
Browse all the conditions that are associated with Thrombocytopenia:
- Thrombocytopenia (4,873 conditions)
Related publications that referenced our studies
- YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
- YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on potassium (the active ingredients of Potassium phosphate) and Potassium phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Memory Loss and drugs of ingredients of desmopressin acetate - now
- Blindness and drugs of ingredients of deferoxamine mesylate - now
- Compression Fracture and drugs of ingredients of budesonide - 2 seconds ago
- Enbrel and Hair Loss for Women aged 20-29 - 3 seconds ago
- Enbrel and Hair Thinning for Women aged 20-29 - 3 seconds ago
- Enbrel and Loss Of Hair for Women aged 20-29 - 3 seconds ago
- Enbrel and Hairloss for Women aged 20-29 - 4 seconds ago
- Enbrel and Baldness for Women aged 20-29 - 4 seconds ago
- Enbrel and Alopecia for Women aged 20-29 - 4 seconds ago
- Could Peridex cause Sinus Disorder? - 5 seconds ago